RESUMO
Endobronchial coils are a relatively novel endoscopic lung volume reduction modality that aims to increase functional capacity in chronic obstructive pulmonary disease (COPD) patients. Two major trials have studied the safety and efficacy of this therapy, but long-term safety has not been studied. Adverse events reported are mainly periprocedural pneumothoraces and early bacterial infectious complications. We report the case of a patient with severe emphysema (Global Initiative for Chronic Obstructive Lung Disease stage IV COPD) who developed endobronchial coil-associated aspergillomas 3 years after coil placement.
Assuntos
Broncoscopia , Corpos Estranhos/diagnóstico por imagem , Pneumonectomia , Aspergilose Pulmonar/diagnóstico por imagem , Enfisema Pulmonar/cirurgia , Instrumentos Cirúrgicos , Infecção da Ferida Cirúrgica/diagnóstico por imagem , Idoso , Antifúngicos/uso terapêutico , Técnicas de Cultura , Volume Expiratório Forçado , Humanos , Masculino , Testes de Precipitina , Aspergilose Pulmonar/diagnóstico , Aspergilose Pulmonar/tratamento farmacológico , Enfisema Pulmonar/fisiopatologia , Índice de Gravidade de Doença , Infecção da Ferida Cirúrgica/diagnóstico , Infecção da Ferida Cirúrgica/tratamento farmacológico , Tomografia Computadorizada por Raios X , Voriconazol/uso terapêuticoRESUMO
Standard bronchoscopy and EBUS-TBNA have good diagnostic yield and are relatively safe procedures in the setting of SVCS. However, complications may arise from the underlying malignancy and its proximity to central vital structures. https://bit.ly/37HXFUY.